
Health News
Study demonstrates the effectiveness of raloxifene in treating inflammatory processes associated with COVID-19
02/16/2021
Researchers from the UPC’s Molecular Biotechnology Centre show that a drug for osteoporosis called raloxifene may inhibit molecules involved in the inflammatory processes associated with COVID-19. About 20%
Read More